• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021.2020 年 4 月至 2021 年 8 月期间,美国急诊科治疗的 COVID-19 成年患者合并精神和物质使用障碍的住院情况。
JAMA Psychiatry. 2023 Apr 1;80(4):331-341. doi: 10.1001/jamapsychiatry.2022.5047.
2
Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study.大麻使用、物质使用障碍和精神诊断对 COVID-19 结局的影响:一项回顾性队列研究。
J Clin Psychiatry. 2022 Aug 29;83(5):21m14332. doi: 10.4088/JCP.21m14332.
3
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.加拿大情绪与焦虑治疗网络(CANMAT)特别工作组关于情绪障碍合并物质使用障碍患者管理的建议。
Ann Clin Psychiatry. 2012 Feb;24(1):38-55.
4
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy.妊娠合并行为和医学共病与大麻使用障碍的关联。
JAMA Psychiatry. 2022 Jan 1;79(1):50-58. doi: 10.1001/jamapsychiatry.2021.3193.
5
Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults.寻求治疗的成年人中注意力缺陷多动障碍与物质使用障碍共病的复杂性和慢性化
Drug Alcohol Rev. 2015 Nov;34(6):683-93. doi: 10.1111/dar.12249. Epub 2015 Mar 18.
6
Assessment of Annual Cost of Substance Use Disorder in US Hospitals.评估美国医院物质使用障碍的年度成本。
JAMA Netw Open. 2021 Mar 1;4(3):e210242. doi: 10.1001/jamanetworkopen.2021.0242.
7
How emergency department visits for substance use disorders have evolved during the early COVID-19 pandemic.在 COVID-19 大流行早期,急诊就诊治疗物质使用障碍的情况是如何演变的。
J Subst Abuse Treat. 2021 Oct;129:108391. doi: 10.1016/j.jsat.2021.108391. Epub 2021 Apr 9.
8
Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.注意缺陷多动障碍与物质使用障碍治疗寻求者的全球严重程度特征。
Eur Addict Res. 2020;26(4-5):201-210. doi: 10.1159/000508546. Epub 2020 Jun 22.
9
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.共患物质使用障碍和注意缺陷多动障碍的临床病程:INCAS 研究的方案和临床特征。
BMC Psychiatry. 2022 Sep 23;22(1):625. doi: 10.1186/s12888-022-04259-6.
10
Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity.囚犯中的注意缺陷多动障碍:物质使用障碍严重程度和精神共病增加。
Eur Addict Res. 2020;26(4-5):179-190. doi: 10.1159/000508829. Epub 2020 Jul 2.

引用本文的文献

1
Impact of substance use disorders on critical care management and health outcomes in septic adolescents.物质使用障碍对脓毒症青少年重症监护管理及健康结局的影响。
Ann Intensive Care. 2025 May 10;15(1):63. doi: 10.1186/s13613-025-01482-8.
2
Exploring the Role of Psychologists on Addiction Consult Services in Acute Care Settings.探索心理学家在急性护理环境中成瘾咨询服务中的作用。
J Clin Psychol Med Settings. 2025 Apr 26. doi: 10.1007/s10880-025-10081-5.
3
Association of chronic opioid therapy and opioid use disorder with COVID-19-related hospitalization and mortality: Evidence from three health systems in the United States.慢性阿片类药物治疗及阿片类药物使用障碍与新冠病毒相关住院治疗和死亡率的关联:来自美国三个医疗系统的证据
Prev Med Rep. 2024 Jul 25;46:102832. doi: 10.1016/j.pmedr.2024.102832. eCollection 2024 Oct.
4
Abstinence duration and psychopathology among addiction outpatients during 18 months of COVID-19.新冠疫情18个月期间成瘾门诊患者的禁欲时长与精神病理学
Front Psychiatry. 2024 Feb 8;15:1339730. doi: 10.3389/fpsyt.2024.1339730. eCollection 2024.
5
Patterns of admission in forensic units during the COVID-19 pandemic: a process analysis.新冠疫情期间法医单位的收治模式:一项过程分析
Front Psychiatry. 2024 Jan 11;14:1339545. doi: 10.3389/fpsyt.2023.1339545. eCollection 2023.
6
Effects of Buprenorphine, Methadone and Substance-Use on COVID-19 Morbidity and Mortality.丁丙诺啡、美沙酮及物质使用对新型冠状病毒肺炎发病率和死亡率的影响
medRxiv. 2023 Nov 27:2023.11.24.23298995. doi: 10.1101/2023.11.24.23298995.
7
Incidence of SARS-CoV-2 and all-cause mortality in persons with co-occurring substance use disorder and mental illness during the pandemic: a Norwegian cohort study.大流行期间合并物质使用障碍和精神疾病的患者中 SARS-CoV-2 感染率和全因死亡率:一项挪威队列研究。
Soc Psychiatry Psychiatr Epidemiol. 2024 Aug;59(8):1379-1387. doi: 10.1007/s00127-023-02599-6. Epub 2023 Nov 28.
8
Self-medication of pain and discomfort with alcohol and other substances by people with HIV infection and substance use disorder: preliminary findings from a secondary analysis.HIV 感染者和物质使用障碍者自行用酒精和其他物质治疗疼痛和不适:二次分析的初步结果。
AIDS Care. 2024 Mar;36(3):414-424. doi: 10.1080/09540121.2023.2275047. Epub 2023 Nov 1.
9
Female sex and burden of depressive symptoms predict insufficient response to telemedical treatment in adult attention-deficit/hyperactivity disorder: results from a naturalistic patient cohort during the COVID-19 pandemic.女性性别和抑郁症状负担预示着成人注意力缺陷多动障碍患者对远程医疗治疗反应不足:COVID-19大流行期间一项自然主义患者队列研究的结果
Front Psychiatry. 2023 Oct 5;14:1193898. doi: 10.3389/fpsyt.2023.1193898. eCollection 2023.
10
COVID-19 risk, course and outcome in people with mental disorders: a systematic review and meta-analyses.COVID-19 风险、病程和结局在精神障碍患者中的研究:系统综述和荟萃分析。
Epidemiol Psychiatr Sci. 2023 Oct 20;32:e61. doi: 10.1017/S2045796023000719.

2020 年 4 月至 2021 年 8 月期间,美国急诊科治疗的 COVID-19 成年患者合并精神和物质使用障碍的住院情况。

Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021.

机构信息

Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.

Division of Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.

出版信息

JAMA Psychiatry. 2023 Apr 1;80(4):331-341. doi: 10.1001/jamapsychiatry.2022.5047.

DOI:10.1001/jamapsychiatry.2022.5047
PMID:36790774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9932946/
Abstract

IMPORTANCE

During the COVID-19 pandemic, US emergency department (ED) visits for psychiatric disorders (PDs) and drug overdoses increased. Psychiatric disorders and substance use disorders (SUDs) independently increased the risk of COVID-19 hospitalization, yet their effect together is unknown.

OBJECTIVE

To assess how comorbid PD and SUD are associated with the probability of hospitalization among ED patients with COVID-19.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cross-sectional study analyzed discharge data for adults (age ≥18 years) with a COVID-19 diagnosis treated in 970 EDs and inpatient hospitals in the United States from April 2020 to August 2021.

EXPOSURES

Any past diagnosis of (1) SUD from opioids, stimulants, alcohol, cannabis, cocaine, sedatives, or other substances and/or (2) PD, including attention-deficit/hyperactivity disorder (ADHD), anxiety, bipolar disorder, major depression, other mood disorder, posttraumatic stress disorder (PTSD), or schizophrenia.

MAIN OUTCOMES AND MEASURES

The main outcome was any hospitalization. Differences in probability of hospitalization were calculated to assess its association with both PD and SUD compared with PD alone, SUD alone, or neither condition.

RESULTS

Of 1 274 219 ED patients with COVID-19 (mean [SD] age, 54.6 [19.1] years; 667 638 women [52.4%]), 18.6% had a PD (mean age, 59.0 years; 37.7% men), 4.6% had a SUD (mean age, 50.1 years; 61.7% men), and 2.3% had both (mean age, 50.4 years; 53.1% men). The most common PDs were anxiety (12.9%), major depression (9.8%), poly (≥2) PDs (6.4%), and schizophrenia (1.4%). The most common SUDs involved alcohol (2.1%), cannabis (1.3%), opioids (1.0%), and poly (≥2) SUDs (0.9%). Prevalence of SUD among patients with PTSD, schizophrenia, other mood disorder, or ADHD each exceeded 21%. Based on significant specific PD-SUD pairs (Q < .05), probability of hospitalization of those with both PD and SUD was higher than those with (1) neither condition by a weighted mean of 20 percentage points (range, 6 to 36; IQR, 16 to 25); (2) PD alone by 12 percentage points (range, -4 to 31; IQR, 8 to 16); and (3) SUD alone by 4 percentage points (range, -7 to 15; IQR, -2 to 7). Associations varied by types of PD and SUD. Substance use disorder was a stronger predictor of hospitalization than PD.

CONCLUSIONS AND RELEVANCE

This study found that patients with both PD and SUD had a greater probability of hospitalization, compared with those with either disorder alone or neither disorder. Substance use disorders appear to have a greater association than PDs with the probability of hospitalization. Overlooking possible coexisting PD and SUD in ED patients with COVID-19 can underestimate the likelihood of hospitalization. Screening and assessment of both conditions are needed.

摘要

重要性

在 COVID-19 大流行期间,美国急诊科 (ED) 因精神障碍 (PD) 和药物过量就诊的人数有所增加。精神障碍和物质使用障碍 (SUD) 独立增加了 COVID-19 住院的风险,但它们一起的影响尚不清楚。

目的

评估共患 PD 和 SUD 与急诊科 COVID-19 患者住院概率的关系。

设计、地点和参与者:这是一项回顾性横断面研究,分析了美国 970 家急诊科和住院医院 2020 年 4 月至 2021 年 8 月期间治疗的患有 COVID-19 的成年人(年龄≥18 岁)的出院数据。

暴露情况

过去诊断为(1)阿片类药物、兴奋剂、酒精、大麻、可卡因、镇静剂或其他物质的 SUD,和/或(2)PD,包括注意力缺陷/多动障碍 (ADHD)、焦虑症、双相情感障碍、重度抑郁症、其他心境障碍、创伤后应激障碍 (PTSD) 或精神分裂症。

主要结果和测量

主要结果是任何住院治疗。计算概率差异,以评估其与 PD 和 SUD 的关系,与 PD 单独、SUD 单独或两种情况都没有相比。

结果

在 1274219 名患有 COVID-19 的急诊科患者中(平均[标准差]年龄,54.6[19.1]岁;667638 名女性[52.4%]),18.6%有 PD(平均年龄,59.0 岁;37.7%男性),4.6%有 SUD(平均年龄,50.1 岁;61.7%男性),2.3%有两者(平均年龄,50.4 岁;53.1%男性)。最常见的 PD 是焦虑症(12.9%)、重度抑郁症(9.8%)、多种(≥2 种)PD(6.4%)和精神分裂症(1.4%)。最常见的 SUD 涉及酒精(2.1%)、大麻(1.3%)、阿片类药物(1.0%)和多种(≥2 种)SUD(0.9%)。在 PTSD、精神分裂症、其他心境障碍或 ADHD 患者中,SUD 的患病率均超过 21%。根据显著的特定 PD-SUD 对(Q <.05),与没有任何疾病的患者相比,PD 和 SUD 均有的患者住院概率高出 20 个百分点(范围,6 至 36;IQR,16 至 25);(2)PD 单独的患者高出 12 个百分点(范围,-4 至 31;IQR,8 至 16);(3)SUD 单独高出 4 个百分点(范围,-7 至 15;IQR,-2 至 7)。关联因 PD 和 SUD 的类型而异。物质使用障碍是住院概率的比 PD 更强的预测因素。

结论和相关性

本研究发现,与单独存在 PD 或任何一种疾病或不存在疾病的患者相比,PD 和 SUD 并存的患者住院的可能性更大。与 PD 相比,物质使用障碍与住院概率的关系更大。在急诊科患有 COVID-19 的患者中,可能会忽略共患 PD 和 SUD 的情况,从而低估住院的可能性。需要对两种情况进行筛查和评估。